PATENT CLAIM ANALYSIS

Application Number: 15757819
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "094610"]

Abstract:
Provided are compositions and articles of manufacture useful for the prophylactic and therapeutic amelioration and treatment of gram-positive bacteria, including bacilli, and related conditions. The compositions and methods incorporate and utilize  Clostridium difficile  derived bacteriophage lysins, particularly PlyCD truncations. Methods for treatment of humans and non-human mammals are provided.

Claim (Index 9):
The method of  claim 8 , wherein the commensal bacteria are selected from  C. septicum, C. novyi, E. faecalis, E. faecium, L. rhamnosous , and combinations thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.41026
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14685696', '14112963', '15492128', '14399588', '11916208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7423540311052509
- 35 USC 102 Novelty (BERT): 0.5437664707943651
- Combined Prediction Score: 0.7224952750741622
- Mean Citation Score: 360.80444400000016
- Max Citation Score: 379.14075
- Similarity Product: 259.9812865347415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test